Jacobs Levy Equity Management
CDLX icon

Jacobs Levy Equity Management’s Cardlytics CDLX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.8K Sell
5,310
-58,552
-92% -$571K ﹤0.01% 948
2025
Q4 		$734K Buy
+63,862
New +$986K ﹤0.01% 739
2025
Q3 		– Sell
-14,548
Closed -$239K – 987
2025
Q2 		$239K Sell
14,548
-56
-0.4% -$967 ﹤0.01% 966
2025
Q1 		$266K Sell
14,604
-10,801
-43% -$309K ﹤0.01% 996
2024
Q4 		$943K Sell
25,405
-6,359
-20% -$243K ﹤0.01% 722
2024
Q3 		$1.02M Buy
31,764
+11,396
+56% +$632K ﹤0.01% 719
2024
Q2 		$1.67M Sell
20,368
-2,054
-9% -$222K 0.01% 637
2024
Q1 		$3.25M Sell
22,422
-20,161
-47% -$1.7M 0.01% 505
2023
Q4 		$3.92M Buy
42,583
+21,589
+103% +$2.19M 0.02% 476
2023
Q3 		$3.46M Sell
20,994
-15,092
-42% -$1.96M 0.02% 446
2023
Q2 		$2.28M Sell
36,086
-5,739
-14% -$348K 0.01% 542
2023
Q1 		$1.42M Buy
41,825
+291
+0.7% +$15.2K 0.01% 634
2022
Q4 		$2.4M Buy
+41,534
New +$2.57M 0.02% 517
2021
Q1 		– Sell
-433
Closed -$618K – 1024
2020
Q4 		$618K Buy
+433
New +$462K 0.01% 818

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jacobs Levy Equity Management's CDLX Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its Cardlytics (CDLX) stake by 92% in Q1 2026, selling an estimated $571K and leaving 5,310 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Jacobs Levy Equity Management first reported a position in CDLX in Q4 2020 and has held it in 14 quarters since. The position peaked at $3.92M in Q4 2023. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Jacobs Levy Equity Management held 5,310 shares of Cardlytics worth $55.8K as of Q1 2026.
  • Jacobs Levy Equity Management sold 58,552 Cardlytics shares in Q1 2026, an estimated $571K.
  • Cardlytics made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #948 holding.
  • Jacobs Levy Equity Management first reported a position in Cardlytics in Q4 2020 and has held it in 14 quarters since.
  • Jacobs Levy Equity Management's Cardlytics position peaked at $3.92M in Q4 2023.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.